567 related articles for article (PubMed ID: 22236965)
1. Cytokine network in psoriasis revisited.
Michalak-Stoma A; Pietrzak A; Szepietowski JC; Zalewska-Janowska A; Paszkowski T; Chodorowska G
Eur Cytokine Netw; 2011 Dec; 22(4):160-8. PubMed ID: 22236965
[TBL] [Abstract][Full Text] [Related]
2. Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle.
Farkas A; Kemény L
Int Immunopharmacol; 2012 Jun; 13(2):215-8. PubMed ID: 22522054
[TBL] [Abstract][Full Text] [Related]
3. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis.
Campanati A; Orciani M; Consales V; Lazzarini R; Ganzetti G; Di Benedetto G; Di Primio R; Offidani A
Arch Dermatol Res; 2014 Dec; 306(10):915-20. PubMed ID: 25160906
[TBL] [Abstract][Full Text] [Related]
4. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.
Quaglino P; Bergallo M; Ponti R; Barberio E; Cicchelli S; Buffa E; Comessatti A; Costa C; Terlizzi ME; Astegiano S; Novelli M; Cavallo R; Bernengo MG
Dermatology; 2011; 223(1):57-67. PubMed ID: 21865674
[TBL] [Abstract][Full Text] [Related]
5. The roles of cells and cytokines in the pathogenesis of psoriasis.
Coimbra S; Figueiredo A; Castro E; Rocha-Pereira P; Santos-Silva A
Int J Dermatol; 2012 Apr; 51(4):389-95; quiz 395-8. PubMed ID: 22435425
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity in the pathogenesis of psoriasis.
Sweeney CM; Tobin AM; Kirby B
Arch Dermatol Res; 2011 Dec; 303(10):691-705. PubMed ID: 21863252
[TBL] [Abstract][Full Text] [Related]
7. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
[TBL] [Abstract][Full Text] [Related]
9. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
[TBL] [Abstract][Full Text] [Related]
10. A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis.
Choe YB; Hwang YJ; Hahn HJ; Jung JW; Jung HJ; Lee YW; Ahn KJ; Youn JI
Br J Dermatol; 2012 Oct; 167(4):762-7. PubMed ID: 22564054
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.
Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P
Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555
[TBL] [Abstract][Full Text] [Related]
13. TNF-α inhibitors reduce the pathological Th
Campanati A; Orciani M; Lazzarini R; Ganzetti G; Consales V; Sorgentoni G; Di Primio R; Offidani A
Exp Dermatol; 2017 Apr; 26(4):319-324. PubMed ID: 27376466
[TBL] [Abstract][Full Text] [Related]
14. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
15. Myeloid but not plasmacytoid blood DCs possess Th1 polarizing and Th1/Th17 recruiting capacity in psoriasis.
Khasawneh A; Baráth S; Medgyesi B; Béke G; Dajnoki Z; Gáspár K; Jenei A; Pogácsás L; Pázmándi K; Gaál J; Bácsi A; Szegedi A; Kapitány A
Immunol Lett; 2017 Sep; 189():109-113. PubMed ID: 28414181
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Th17 pathway in psoriasis.
Elloso MM; Gomez-Angelats M; Fourie AM
J Leukoc Biol; 2012 Dec; 92(6):1187-97. PubMed ID: 22962689
[TBL] [Abstract][Full Text] [Related]
17. Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway.
Balato A; Schiattarella M; Di Caprio R; Lembo S; Mattii M; Balato N; Ayala F
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1016-24. PubMed ID: 24033358
[TBL] [Abstract][Full Text] [Related]
18. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
[TBL] [Abstract][Full Text] [Related]
19. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice.
Bai S; Zhang Z; Hou S; Liu X
Mol Med Rep; 2016 Jul; 14(1):671-80. PubMed ID: 27221314
[TBL] [Abstract][Full Text] [Related]
20. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis.
Nakajima K
J Dermatol; 2012 Mar; 39(3):219-24. PubMed ID: 22352845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]